Canaccord lowered the firm’s price target on Progyny (PGNY) PGNY) to $21 from $23 and keeps a Hold rating on the shares. The firm said they posted a second consecutive quarter of solid results to kick off 2025, well ahead of Canaccord and consensus estimates. The extended services offered to certain Amazon (AMZN) members contributed roughly $2 million more than contemplated in guidance provided last quarter.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PGNY: